Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.
Compounding Theme Archive
INFUSION AND STERILE PREPARATIONS

INFUSION AND STERILE PREPARATIONS

Permanent storage and easy retrieval of Journal articles and formulations.
  - Includes the full-color, searchable, PDF files of articles and formulations from the Journal.
  - Print Journal articles in color for your research and marketing needs.
  - Eliminate long searches through past issues for articles and formulations.



Only $95.00


(Select Format)
Mailed CD
Instant PDF Download

This archive contains the following articles listed by volume, issue and page number:

INFUSION RELATED ARTICLES
Title (Click for Details) Vol/Issue Page
Antineoplastic Drug Contamination on the Outside of Prepared Infusion Bags Vol. 22 No. 4 345
U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List) Vol. 20 No. 6 457
Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures Vol. 20 No. 4 328
Physical and Chemical Stability of Urapidil in 0.9% Sodium Chloride in Elastomeric Infusion Pump Vol. 20 No. 4 343
Compatibility of Norepinephrine Bitartrate with Levofloxacin and Moxifloxacin During Simulated Y-site Administration Vol. 20 No. 3 236
Long-term Stability of Esomeprazole in 5% Dextrose Infusion Polyolefin Bags at 5°C ± 3°C after Microwave Freeze-thaw Treatment Vol. 19 No. 6 521
In-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers Vol. 19 No. 5 432
Use of 8.4% Sodium Bicarbonate in Buffering Commonly Administered Vancomycin Hydrochloride Solutions for Use with Midline or Peripheral Line Catheters Vol. 19 No. 4 334
Basics of Compounding Sterile Preparations: Nomenclature and Considerations Vol. 18 No. 4 313
Morphine 6-mg/mL, Haloperidol 0.5-mg/mL, and Hyoscine 6-mg/mL Infusion Vol. 15 No. 6 504
Home Infusion: Overview of the Infusion Patient-Care Process Vol. 15 No. 4 270
Stability of Ertapenem in an Elastomeric Infusion Device Vol. 15 No. 3 252
Compatibility of Parenteral Furosemide with Seventeen Secondary Drugs Used in Standard Concentrations Vol. 15 No. 3 259
Home Infusion: Available Vascular Access Devices and Common Therapies Vol. 15 No. 3 183
Home Infusion Basics for the Non-Infusion Pharmacist Vol. 15 No. 2 94
Home Infusion Accreditation: Another Quality Recognition Branding Tool Vol. 14 No. 5 360
Stability and Compatibility of Reconstituted Caspofungin in Select Elastomeric Infusion Device Vol. 14 No. 5 436
Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration Vol. 12 No. 2 170
Compatibility and Stability of Aloxi (Palonosetron Hydrochloride) Admixed With Dexamethasone Sodium Phosphate Vol. 8 No. 5 398
Chemical Stability of Terbutaline Sulfate Injection After Diluting With Normal Saline When Stored at Room Temperature in Polyvinylchloride Bags Vol. 8 No. 5 404
A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards Vol. 8 No. 4 251
Stability of Zidovudine and Ranitidine in 0.9% sodium Chloride and 5% Dextrose Injections Stored at Ambient Temperature (23 ± 2°C) and 4°C in 50-mL Polyvinylchloride Bags Up to 24 Hours. Vol. 8 No. 3 236
Hydromorphone HCl 20-mg/mL and Bupivacaine HCl 7.5-mg/mL Injection Vol. 8 No. 2 136
Chemical Stability of Phenylephrine HCl After Reconstitution in 0.9% Sodium Chloride Injection for Infusion Vol. 8 No. 2 153
Effect of Freezing, Long-Term Storage and Microwave Thawing on the Stability of Tramadol in 5% Dextrose Infusion in Polyvinyl Chloride Bags Vol. 8 No. 2 156
PostScription: Cleanroom Standards Vol. 8 No. 2 160
Hydrochloric Acid 0.1-N Injection Vol. 8 No. 1 55
Stability of Zidovudine and Dobutamine HCl Injections in 0.9% Sodium Chloride and 5% Dextrose Injections Stored at Ambient Temperature (23 ± 2°C) and 4°C in 50-mL Polyvinyl Chloride Bags Up to 24 Hours Vol. 8 No. 1 73
Chemical Stability of Cefuroxime Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use Vol. 7 No. 4 310
Phenytoin Injections: From Compounding to Cerebyx Vol. 6 No. 6 410
Establishing and Standardizing Preferred Pharmacy Practices in a Multioffice Infusion Company, Part 1 Vol. 6 No. 6 428
Total Parenteral Nutrition for Animals Vol. 6 No. 5 328
A Review of Parenteral Admixtures Requiring Select Containers and Administration Sets Vol. 6 No. 2 120
Creating a Productivity Measurement Tool for a Home Infusion Pharmacy Vol. 6 No. 1 24
New Perspectives on Vancomycin Use in Home Care, Part 2: Delivery Systems Vol. 6 No. 1 55
Ceftazidime 20-mg/mL for Ambulatory Infusion Pump Vol. 5 No. 6 451
New Perspectives on Vancomycin Use in Home Care, Part 1 Vol. 5 No. 6 465
Stability of Ephedrine Sulfate at Ambient Temperature and 4°C in Polypropylene Syringes Vol. 5 No. 5 394
Assessment of the Stability of Teicoplanin in Intravenous Infusions Vol. 5 No. 5 397
PostScription: pH Values of Nafcillin Sodium in 0.9% Sodium Chloride Injection After the Addition of Sodium Bicarbonate Injection To Prevent Phlebitis - A Letter to the Editor Vol. 5 No. 4 328
Compatibility Screening of Hextend During Simulated Y-Site Administration with Other Drugs Vol. 5 No. 1 69
Stability of Ethacrynate Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use Vol. 5 No. 1 73
Stability of Acyclovir Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use Vol. 5 No. 1 75
Disposable Ambulatory Infusion Devices: A Review - Part 3 Vol. 4 No .6 442
Ambulatory Syringe Infusion Devices: A Review - Part 2 Vol. 4 No. 5 364
Short Communication: Compounding for Implantable Pumps Vol. 4 No. 4 280
Ambulatory Pumps: Part I of a Three-Part Series - Peristaltic Infusion Devices Review Vol. 4 No. 4 281
Needleless Infusion Systems Vol. 4 No. 3 183
Stability of Ranitidine Hydrochloride with Cefazolin Sodium, Cefbuperazone Sodium, Cefoxitin Sodium and Cephalothin Sodium during Simulated Y-Site Administration Vol. 4 No. 2 150
Stability of Alatrofloxacin Mesylate in 5% Dextrose Injection and 0.45% Sodium-Chloride Injection Vol. 4 No. 1 66
Electronically Controlled Drug Delivery Vol. 3 No. 6 439
Compounding Radiolabeled Blood Cells for Diagnostic Imaging Vol. 3 No. 6 443
Stability of Dobutamine Hydrochloride 4 mg/mL in 5% Dextrose Injection at 5 and 23 degrees C Vol. 3 No. 5 412
Catheter Occlusion: Causes and Solutions Vol. 2 No. 5 342
TPN Bulk Compounding from Bulk Drug Substances Vol. 2 No. 5 347
The Feasibility and Benefits of TPN in Horses: A Review of the Findings Vol. 2 No. 5 351
Model Parenteral Nutrition Formulation (Veterinary) Vol. 2 No. 5 352
Required Documentation for Home Infusion Pharmacies - Compounding Records Vol. 2 No. 5 354
Adult Peripheral Parenteral Nutrition Solution with 4.23% Amino Acids Vol. 2 No. 5 366
Adult Peripheral Parenteral Nutrition Solution with 2.5% Amino Acids Vol. 2 No. 5 367
Three-in-One Adult Total Parenteral Nutrition Vol. 2 No. 5 371
Compatibility of Paclitaxel Injection Diluent with Two Reduced-Phthalate Administration Sets for the Acclaim Pump Vol. 2 No. 5 382
Stability of Magnesium Sulfate in 0.9% Sodium Chloride and Lactated Ringers Solutions Vol. 2 No. 5 385
Cleaning, Inspecting and Flow-Accuracy Testing of Ambulatory Pumps Vol. 1 No. 6 430
Home Infusion and Alternative-Site Health Care: The Big Picture Vol. 1 No. 5 294
Continued Growth Predicted for Home Infusion Market Vol. 1 No. 5 298
Drug Stability and Compatibility: Special Considerations for Home Health Care Vol. 1 No. 5 301
Ambulatory Infusion Pump Review Vol. 1 No. 5 306
Effect of Fat Emulsion and Supersaturation in Parenteral Nutrition Admixtures Vol. 1 No. 1 54

STERILE PREPARATIONS RELATED ARTICLES
Title (Click for Details) Vol/Issue Page
Primary Engineering Controls in Pharmaceutical Compounding, Part 1: Unidirectional-airflow Workstations, Compounding Aseptic Isolators, and Compounding Aseptic Containment Isolators Vol. 23 No. 6 447
How to Qualify Container Closure Systems for Intended Use, Part 1 Vol. 23 No. 6 454
Quality Control: Hand and Glove Sanitizing in Sterile Compounding, Part 2 Vol. 23 No. 6 467
Intravenous Admixture Preparation Considerations, Part 1: Overview of Series on Personnel Selection for Intravenous Admixture Compounding Vol. 23 No. 6 478
Quality Control: Hand and Glove Sanitizing in Sterile Compounding, Part 1 Vol. 23 No. 5 387
Sterile Basics: Pharmaceutical Waters Used in Sterile and Nonsterile Compounding Vol. 23 No. 5 399
Summary of Quality-Control Testing for Sterile and Nonsterile Compounded Preparations, Part 2: Microbiological Testing Vol. 23 No. 4 299
Basics of Sterile Compounding: Vehicles Used in Sterile Compounding Vol. 23 No. 3 221
Evaluation of the Quality of Sterile Compounding Videos Available on the YouTube Video-sharing Website Vol. 23 No. 3 238
Basics of Compounding for Sterile, Nonsterile, and Quality Control Compounding: Process Analytical Technology: Appropriate for Sterile and Nonsterile Compounding? Vol. 23 No. 2 123
Quality Control and Basics of Sterile Compounding: Attempting to Avoid Out-of-Specification Results and Patient Harm in Sterile Compounding Vol. 23 No. 1 47
Basics of Sterile Compounding. Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 2 Vol. 22 No. 6 475
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations Vol. 22 No. 5 387
Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1 Vol. 22 No. 5 401
Cysteamine 0.5% Ophthalmic Solution Vol. 22 No. 5 408
Basics of Sterile Compounding: Criteria for Determining Beyond-use Dating Vol. 22 No. 4 303
Quality Control–Sterile Compounding: Analytical Methods. Density Determinations and Quality Control in Nonsterile and Sterile Compounding Vol. 22 No. 3 206
Dorzolamide 2% Ophthalmic Solution Vol. 22 No. 3 234
Rolapitant Injectable Emulsion with Dexamethasone Sodium Phosphate Admixture Vol. 22 No. 3 237
Quality Control: Lessons Learned from a Trimix Stability Study in a 503A Compounding Pharmacy Vol. 22 No. 2 129
Dorzolamide 2% and Timolol 0.5% Ophthalmic Solution Vol. 22 No. 2 147
Rolapitant Injectable Emulsion with Palonosetron Hydrochloride Admixture Vol. 22 No. 2 151
Sterile Basics of Compounding: Relationship Between Syringe Size and Dosing Accuracy Vol. 22 No. 1 41
Glutamate and Aspartate Cardioplegia Additive Solution Vol. 22 No. 1 50
Sodium Citrate 9% Nasal Spray for Olfactory Disorders Vol. 22 No. 1 57
Haloperidol 5-mg/mL Injection Vol. 21 No. 6 493
Trace Elements Injection 5 Vol. 21 No. 6 498
Vancomycin 5-mg/mL Injection Vol. 21 No. 6 499
Basics of Sterile Compounding: Particulate Matter Vol. 21 No. 5 395
Acetylcysteine Solutions for Inhalation Vol. 21 No. 5 408
Etoposide 20-mg/mL Injection Vol. 21 No. 5 410
Fentanyl Citrate 50-mcg/mL Injection Vol. 21 No. 5 411
Ioversol Injection Vol. 21 No. 5 413
Peritoneal Dialysis Solution with 1.5%, 2.5%, or 4.25% Dextrose Vol. 21 No. 5 415
Tacrolimus 0.3-mg/mL Ophthalmic Solution Vol. 21 No. 5 416
Stability of Dalteparin 1,000 Unit/mL in 0.9% Sodium Chloride for Injection in Polypropylene Syringes Vol. 21 No. 5 426
Stability of Dexmedetomidine in 0.9% Sodium Chloride in Two Types of Intravenous Infusion Bags Vol. 21 No. 5 436
Component Selection for Sterile Compounding Vol. 21 No. 4 277
Basics of Sterile Compounding: Excipients Used in Injections Vol. 21 No. 4 301
Reteplase Injection Vol. 21 No. 4 317
Tacrolimus 0.06% Ophthalmic Drops Vol. 21 No. 4 319
Torsemide 10-mg/mL Injection Vol. 21 No. 4 320
Adventures in the Environmental World and Environmental Microbiology Sampling of Air for Pharmaceutical Sterile Compounding Vol. 21 No. 3 182
Microbiologic Testing for 503A Sterile-Compounding Pharmacies Vol. 21 No. 3 193
Basics of Sterile Compounding: Manipulating Peptides and Proteins Vol. 21 No. 3 223
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies Vol. 21 No. 2 95
Accuracy Considerations in Sterile Compounding Vol. 21 No. 2 133
Stability of Alprostadil in 0.9% Sodium Chloride Stored in Polyvinyl Chloride Containers Vol. 21 No. 2 150
Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms Vol. 21 No. 1 47
Infliximab 1% Ophthalmic Solution Vol. 21 No. 1 62
Tetracaine Hydrochloride 0.5% Ophthalmic Solution Vol. 21 No. 1 64
Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments Vol. 20 No. 6 495
Flumazenil 0.1-mg/mL Injection Vol. 20 No. 6 509
Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions Vol. 20 No. 5 399
Inamrinone 5-mg/mL Injection Vol. 20 No. 5 408
Tromethamine Injection Vol. 20 No. 5 415
Choosing a Vial Processing Line for Aseptic Compounding: Part 1 Vol. 20 No. 4 283
Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding Vol. 20 No. 4 307
Dolasetron Mesylate 20-mg/mL Injection Vol. 20 No. 4 318
Gatifloxacin 0.5% Ophthalmic Solution Vol. 20 No. 4 319
Plasmingen and Hyaluronate Sodium Ophthalmic Solution Vol. 20 No. 4 325
Scopolamine Hydrobromide 0.25% Ophthalmic Solution Vol. 20 No. 4 326
Basics of Sterile Compounding: Clinical Hazards of Injectable Drug Administration Vol. 20 No. 3 217
Carboplatin 50-mg/mL Injection Vol. 20 No. 3 226
Cefotetan Disodium Injection Vol. 20 No. 3 227
Dexamethasone 0.1%, Neomycin 0.35%, and Polymixin 10,000 Units/g Ophthalmic Ointment Vol. 20 No. 3 228
Sodium Nitroprusside 25-mg/mL Injection Vol. 20 No. 3 234
Root Cause Analysis, Part 2: Sterile Compounding Vol. 20 No. 2 99
Formulation and Stability of Solutions Vol. 20 No. 1 41
Dexamethasone, Neomycin, and Polymyxin Ophthalmic Ointment Vol. 20 No. 1 51
Thrombin 1,000 Units/mL Topical Solution, Sterile Vol. 20 No. 1 54
Tropicamide 1% Ophthalmic Solution Vol. 20 No. 1 55
Vancomycin 5% and Amikacin 2% Ophthalmic Solution Vol. 20 No. 1 56
Basics of Sterile Compounding: Sterile Product Packaging and Delivery Systems Vol. 19 No. 6 491
Cefepime Hydrochloride 100-mg/mL Injection Vol. 19 No. 6 505
Cefotaxime 100-mg/mL Injection Vol. 19 No. 6 506
Chlorpromazine Hydrochloride 25-mg/mL Injection, Preserved Vol. 19 No. 6 507
Estradiol Valerate 40-mg/mL in Oil Injection Vol. 19 No. 6 509
Levetiracetam 100-mg/mL Injection (Concentrate) Vol. 19 No. 6 510
Using Hospital Laboratory Services to Perform Quality-control Testing on Compounded Preparations Vol. 19 No. 5 383
Sterile Filtration Vol. 19 No. 5 393
Safer Sterile Compounding: Choosing and Using Disinfectants for the Cleanroom Vol. 19 No. 4 268
Basics of Sterile Compounding: Barrier Isolator Technologist in Aseptic Processing Vol. 19 No. 4 315
Ammonium Molybdate 25-mcg/mL Injection Vol. 19 No. 4 324
Cytarabine 50-mg/mL Injection Vol. 19 No. 4 328
Moxifloxacin Hydrochloride 1.6-mg/mL Intravenous Injection Vol. 19 No. 4 329
Oxytocin 10-units/mL Injection Vol. 19 No. 4 330
Phytonadione 2-mg/mL Injection Vol. 19 No. 4 331
Dry-heat Depyrogenation Ovens for Pharmaceutical Compounding Facilities Vol. 19 No. 3 182
Quality Assurance and Quality Control, Part 2 Vol. 19 No. 3 215
Basics of Sterile Compounding: Contamination Control Vol. 19 No. 3 232
Physostigmine Salicylate 1-mg/mL Injection Vol. 19 No. 3 246
Scopolamine Hydrobromide -.4-mg/mL Injection Vol. 19 No. 3 247
Protocol of Blood Serum Eye Drops Vol. 19 No. 3 252
Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under In-use Conditions with Different Administration Materials Vol. 19 No. 3 261
New England Compounding Center Indictment Vol. 19 No. 2 94
Quality Assurance and Quality Control, Part 1 Vol. 19 No. 2 121
Basics of Sterile Compounding: Sterilization Methods in Sterile Product Manufacturing Vol. 19 No. 2 127
Aminohippurate Sodium 200-mg/mL Injection Vol. 19 No. 2 143
L-Cysteine Hydrochloride 50-mg/mL Injection Vol. 19 No. 2 146
Morrhuate Sodium 5% Injection Vol. 19 No. 2 147
Pancuronium Bromide 1-mg/mL Injection Vol. 19 No. 2 149
Physostigmine Salicylate 1-mg/mL Injection Vol. 19 No. 2 150
Trypan Blue 0.06% Ophthalmic Solution Vol. 19 No. 2 151
Basics of Sterile Compounding: Aseptic Processing Vol. 19 No. 1 49
Cisplatin 1-mg/mL Injection Vol. 19 No. 1 62
Daunorubicin 5-mg/mL Injection Vol. 19 No. 1 63
Erythromycin 50-mg/mL Injection Vol. 19 No. 1 64
Hydralazine Hydrochloride 20-mg/mL Injection Vol. 19 No. 1 65
Phentolamine Mesylate 5-mg/mL Injection Vol. 19 No. 1 69
PreScription: "Named Formulas" Database Available Vol. 18 No. 6 444
Depyrogenation Options for the Compounding Cleanroom Vol. 18 No. 6 446
Basics of Compounding: Unique and Special Characteristics of Sterile Dosage Forms Vol. 18 No. 6 479
Dexmedetomidine 100 mcg/mL Injection Vol. 18 No. 6 495
Leucovorin 10-mg/mL Injection Vol. 18 No. 6 497
Levocarnitine 200-mg/mL Injection Vol. 18 No. 6 498
Methylene Blue 10-mg/mL Injection Vol. 18 No. 6 500
Oxacillin Sodium 167-mg/mL Injection Vol. 18 No. 6 502
Roboticized Compounding of Oncology Drugs in a Hospital Pharmacy Vol. 18 No. 5 358
Basics of Compounding: Certification of Sterile Equipment and Facilities: What Pharmacists Need to Know Vol. 18 No. 5 397
Azithromycin 100-mg/mL Injection Vol. 18 No. 5 408
Dexpanthenol 250-mg/mL Injection Vol. 18 No. 5 410
Ephedrine Sulfate 50-mg/mL Injection Vol. 18 No. 5 411
Fluorescein 100-mg/mL Injection Vol. 18 No. 5 412
Indocyanine green 2.5-mg/mL Injection Vol. 18 No. 5 413
Vial Washers for the Compounding Pharmacy: Ensuring Preparation Safety Vol. 18 No. 4 270
Basics of Compounding Sterile Preparations: Nomenclature and Considerations Vol. 18 No. 4 313
Atracurium Besylate 10-mg/mL Injection, Preserved Vol. 18 No. 4 322
Calcitriol 1-mcg/mL Injection Vol. 18 No. 4 324
Chloramphenicol 100-mg/mL Injection Vol. 18 No. 4 325
Indigo Carmine Injection Vol. 18 No. 4 329
Propranolol Hydrochloride 1-mg/mL Injection Vol. 18 No. 4 330
Zinc 1-mg/mL Injection Vol. 18 No. 4 331
Bupivacaine Hydrochloride 0.5% Injection Vol. 18 No. 3 234
Lidocaine Hydrochloride 1% Injection Vol. 18 No. 3 237
A Needle-free Reconstitution and Transfer System for Compounded Sterile Intravenous Drug Solutions: In Compliance with United States Pharmacopeia Chapter <797> Standards Vol. 18 No. 2 94
Quality Control Analytical Methods: The Essentials of United States Pharmacopeia Chapter <51> Antimicrobial Effectiveness Testing and Its Application in Pharmaceutical Compounding Vol. 18 No. 2 123
Basics of Sterile Compounding: Compounding by Weight Versus Compounding by Volume Vol. 18 No. 2 131
Fludarabine Phosphate 25-mg/mL Injection Vol. 18 No. 2 143
Mecasermin 10-mg/mL Injection Vol. 18 No. 2 144
Methylprednisolone 40-mg/mL Injection Vol. 18 No. 2 145
Polymixin B Injection Vol. 18 No. 2 146
Rocuronium Bromide 10-mg/mL Injection Vol. 18 No. 2 147
Selenium 40-mcg/mL Injection Vol. 18 No. 2 149
Sincalide 1-mcg/mL Injection Vol. 18 No. 2 150
Testosterone Enanthate 200-mg/mL Injection Vol. 18 No. 2 151
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013 Vol. 18 No. 1 6
Determination of Risk for Sterile Preparations Vol. 18 No. 1 30
Quality Control Analytical Methods: Laboratory Considerations of United States Pharmacopeia Chapter <71> Sterile Tests and Its Application to Pharmaceutical Compounding Vol. 18 No. 1 46
Basics of Sterile Compounding: Bubble Point Testing Vol. 18 No. 1 54
Aztreonam Injection Vol. 18 No. 1 60
Bumetanide 0.25-mg/mL Injection Vol. 18 No. 1 61
Droperidol 2.5-mg/mL Injection Vol. 18 No. 1 62
Potassium Chloride 2-mEq/mL Injection Vol. 18 No. 1 67
Procainamide Hydrochloride 100-mg/mL Injection Vol. 18 No. 1 68
Vasopressin 20-units/mL Injection Vol. 18 No. 1 69
Improving the Review of Standard Operating Procedures: A Novel Electronic System for Compounding Pharmacies Vol. 17 No. 6 465
Benztropine Mesylate 1-mg/mL Injection Vol. 17 No. 6 498
Cefazolin 250-mg/mL Injection Vol. 17 No. 6 499
Cyclopentolate Hydrochloride 0.2% and Phenylephrine Hydrochloride 1% Ophthalmic Solution Vol. 17 No. 6 502
Dihydroergotamine Mesylate 1-mg/mL Injection Vol. 17 No. 6 503
Compounding Pharmacies: Before and After an Inspection Vol. 17 No. 5 358
Acyclovir 50-mg/mL Injection Vol. 17 No. 5 414
Aminocaproic Acid 250-mg/mL Injection Vol. 17 No. 5 415
Clindamycin 150-mg/mL Injection Vol. 17 No. 5 416
Fluorouracil 50-mg/mL Injection Vol. 17 No. 5 417
Hydroxyzine Hydrochloride 25-mg/mL Injection Vol. 17 No. 5 418
Indomethacin 1-mg/mL Injection Vol. 17 No. 5 419
Mesna 100-mg/mL Injection Vol. 17 No. 5 420
Methotrexate 25-mg/mL Injection Vol. 17 No. 5 421
Phenylephrine Hydrochloride 10-mg/mL Injection Vol. 17 No. 5 422
Terbutaline Sulfate 1-mg/mL Injection Vol. 17 No. 5 423
United States Pharmacopeia Chapter <797> Timeline: 1989 to 2013 Vol. 17 No. 4 283
Quality Control Analytical Methods: End-preparation Assessments and Tests for Compounded Sterile Preparations Vol. 17 No. 4 307
Allopurinol Sodium 4-mg/mL Injection Vol. 17 No. 4 328
Amikacin Sulfate 250-mg/mL Injection Vol. 17 No. 4 329
Dacarbazine 200-mg/mL Injection Vol. 17 No. 4 330
Ketamine 50-mg/mL Injection Vol. 17 No. 4 331
Methohexital Sodium 500-mg/mL Injection Vol. 17 No. 4 332
Metoprolol Tartrate 1-mg/mL Injection Vol. 17 No. 4 333
Succinylcholine Chloride 50-mg/mL Injection Vol. 17 No. 4 335
Decontamination Technology: The Missing Element Vol. 17 No. 3 193
Assessing the Stability of Common Radiopharmaceuticals Compounded and Utilized Outside Package Insert Guidelines Vol. 17 No. 3 238
Sterilization of Compounded Parenteral Products: Verification of Autoclaves Vol. 17 No. 2 94
Quality Control Analytical Methods: Strategies to Ensure a Robust Quality-control Microbiology Program Vol. 17 No. 2 130
Basics of Compounding: Repackaging, Part 2 Vol. 17 No. 2 136
Adenosine 3-mg/mL Injection Vol. 17 No. 2 144
Alcohol Dehydrated Injection Vol. 17 No. 2 145
Ciprofloxacin 10-mg/mL Intravenous Injection Concentrate Vol. 17 No. 2 147
Cyanocobalamin 1000-mcg/mL Injection Vol. 17 No. 2 148
Dexrazoxane 1-mg/mL Injection Vol. 17 No. 2 149
Meropenem 50-mg/mL Injection Vol. 17 No. 2 150
Paclitaxel 6-mg/mL Injection Vol. 17 No. 2 151
Thiotepa 15-mg/mL Injection Vol. 17 No. 2 152
Establishing Benchmark Rates of Microbial and Bacterial Endotoxin Contamination for Radiopharmaceuticals Compounded in Commerical Nuclear Pharmacy Settings Vol. 17 No. 2 168
Basics of Compounding: Repackaging, Part 1 Vol. 17 No. 1 54
Desmopressin 4-mcg/mL Injection Vol. 17 No. 1 64
Dobutamine 10-mg/mL Injection Vol. 17 No. 1 65
Granisetron 1-mg/mL Injection Vol. 17 No. 1 66
Ibuprofen 10-mg/mL Injection Vol. 17 No. 1 67
Mepivacaine Hydrochloride 1% Injection Vol. 17 No. 1 68
Milrinone 0.2-mg/mL Injection Vol. 17 No. 1 69
Neostigmine Methylsulfate 0.5-mg/mL Injection Vol. 17 No. 1 70
Nicardipine Hydrochloride Injection Vol. 17 No. 1 71
Octreotide 50-mcg/mL Injection Vol. 17 No. 1 72
Testosterone Cypionate 100-mg/mL Injection Vol. 17 No. 1 73
Aminophylline 25-mg/mL Injection Vol. 16 No. 6 500
Ammonium Chloride 5-mEq/mL Injection Vol. 16 No. 6 501
Azathioprine 10-mg/mL Injection Vol. 16 No. 6 502
Copper 0.4-mg/mL Injection Vol. 16 No. 6 503
Dipyridamole 5-mg/mL Injection Vol. 16 No. 6 504
Dopamine Hydrochloride 80-mg/mL Injection Vol. 16 No. 6 505
Ergotamine Tartrate 1-mg and Caffeine 100-mg Capsules Vol. 16 No. 6 506
Papaverine Hydrochloride 30-mg/mL Injection Vol. 16 No. 6 507
Valproate Sodium 100-mg/mL Injection Vol. 16 No. 6 508
Vercuronium Bromide 1-mg/mL Injection Vol. 16 No. 6 509
Metronidazole 5-mg/mL Injection Vol. 16 No. 5 425
Doxapram Hydrochloride 20-mg/mL injection Vol. 16 No. 5 418
Enalaprilat 1.25-mg/mL Injection Vol. 16 No. 5 419
Esmolol Hydrochloride 10-mg/mL Injection Vol. 16 No. 5 420
Fluconazole 2-mg/mL Injection Vol. 16 No. 5 421
Haloperidol 50-mg/mL in Oil Injection Vol. 16 No. 5 422
Meperidine Hydrochloride 50-mg/mL Injection Vol. 16 No. 5 423
Methocarbamol 100-mg/mL Injection Vol. 16 No. 5 424
Nalbuphine Hydrochloride 10-mg/mL Injection Vol. 16 No. 5 426
Oxymorphone Hydrochloride 1-mg/mL Injection Vol. 16 No. 5 427
I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease Vol. 16 No. 3 190
PostScription: Best Practice Recommendations for Compounding 17-Hydroxyprogesterone Vol. 16 No. 1 86
Misinterpretation of United States Pharmacopeia Chapter <797> Vol. 16 No. 1 6
Quality-Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 3: Testimonials and Comparisons Vol. 15 No. 5 390
Quality Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 2: USP Waters: Experts at the United States Pharmacopeia Answer Compounders' Questions Vol. 15 No. 3 224
Quality Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 1 Vol. 15 No. 2 133
PreScription: The Resources of the International Journal of Pharmaceutical Compounding, Inc.; Sterile Compounding Meets Needs for Patients, Professionals Vol. 15 No. 1 4
A Technology Guide for Evaluating Software Tools to Support Sterile Compounding and Workflow Management Vol. 15 No. 1 20
Quality-Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 3: A Simplified Endotoxin Test Method for Compounded Sterile Preparations Vol. 15 No. 1 49
Quality-Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 2 Vol. 14 No. 6 493
Home Infusion: Overcoming the Barriers to Entry Vol. 14 No. 6 450
Implementation of a Viable Air-Sampling Program Using a Volumetric Collection Device Vol. 14 No. 5 370
Quality Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 1 Vol. 14 No. 5 407
PostScription: Guidance to Achieve Accreditation from the Pharmacy Compounding Accreditation Board Vol. 14 No. 5 440
PreScription: Sterile Product Outsourcing: Growing Trend in Hospitals Vol. 14 No. 4 268
Developing an Erythromycin Ophthalmic Ointment: Putting the Puzzle Pieces Together Vol. 14 No. 4 270
Quality Control Analytical Methods: Pharmacopeial Bacterial Endotoxins Test Chapters Vol. 14 No. 4 317
Basics of Compounding: Considerations for Implementing USP Chapter <797> Pharmacy Compounding -- Sterile Preparations, Part 20: Patient or Caregiver Training, Patient Monitoring and Adverse Events Reporting, and Quality-Assurance Program Vol. 14 No. 4 328
Basics of Compounding: Considerations for Implementing USP Chapter <797> -- Sterile Preparations, Part 19: Storage and Beyond-Use Dating, Maintaining Sterility, Purity, and Stability of Dispensed and Distributed Compounded Sterile Preparations Vol. 14 No. 3 232
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 18: Verification of Automated Compounding Devices for Parenteral Nutrition Compounding and Finished Preparation Release Checks and Tests Vol. 14 No. 2 142
Chemical Stability of Hydromorphone Hydrochloride in Patient-Controlled Analgesia Injector Vol. 14 No. 2 160
Ophthalmic Toning-Lubricating Drops Vol. 14 No. 1 70
An Academic Practice Partnership: An Innovative Course in Advanced Compounding Vol. 14 No. 1 48
Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmacy Compounding Sterile Preparations, Part 17: Elements of Quality Control Vol. 14 No. 1 60
Autologous Eye Drops for the Treatment of Dry Eye and Neurotrophic Keratitis Vol. 13 No. 6 506
Quality-Control Analytical Methods: Applications and Sterility of Autologous Eye Drops Vol. 13 No. 6 540
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 16: Suggested Standard Operating Procedures Vol. 13 No. 6 546
Stability of Preoperative Cataract Surgery Gel in Polycarbonate Syringes Vol. 13 No. 6 564
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chater <797> Pharmaceutical Compounding--Sterile Preparations, Part 15: Personnel Training, Cleansing, and Garbing Vol. 13 No. 5 420
Preventing Nonmicrobiologic Airborne Contamination in the Compounding Pharmacy: Ensuring a Safe Environment for Compounders, Staff, and Clients Vol. 13 No. 4 290
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 14: Environmental Quality and Control (Continued) Vol. 13 No. 4 322
PostScription: Compounding Pharmacy in Puerto Rico Vol. 13 No. 4 350
Preparing Nonsterile and Sterile Hazardous Compounds in an Institutional Setting Vol. 13 No. 4 300
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 13: Environmental Quality and Control Vol. 13 No. 3 234
Compliance by Hospitals and Healthcare Facilities with the Revised United States Pharmacopeia Chapter <797> Vol. 13 No. 2 94
Tips for Cleanroom Construction and Renovation Vol. 13 No. 2 100
Contract Sterilization and Validation Companies Offer New Options for Sterile Compounded Preparations Vol. 13 No. 2 106
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 12: Sterilization Methods Vol. 13 No. 2 146
Acidified Sodium Hypochlorite for Antisepsis and Disinfection Vol. 13 No. 2 152
Quality Control Analytical Methods: Testing of Electrolytes Solutions Vol. 13 No. 1 53
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 11: Hazardous Drugs Vol. 13 No. 1 56
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 9: Immediate-Use Compounded Sterile Preparations Vol. 12 No. 5 440
Quality-Control Analytical Methods: Overview of Beyond-Use Dating for Compounded Sterile Preparations Vol. 12 No. 6 524
Glycerin, Sterile Vol. 12 No. 6 542
Basics of Compounding: United States Pharmacopeia General Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 10: First Revision: The Main Changes, Events, and Rationale Vol. 12 No. 6 530
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 8; Stability and Beyond-Use Dating Vol. 12 No. 4 344
Microbial Air-Sampling Equipment, Part 2: Experiences of Compounding Pharmacists Vol. 12 No. 4 321
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 7: Microbial Contamination Risk Levels, 12-Hour Use, and Immediate Use Vol. 12 No. 3 252
Microbial Air-Sampling Equipment, Part 1: Meeting United States Pharmacopeia Chapter <797> Standards Vol. 12 No. 3 216
Dilution and Compounding of Ziconotide for Intrathecal Administration Vol. 12 No. 3 200
Quality-Control Analytical Methods: Minimizing the Probability of Out-of-Specification Preparations: Results that Make You Say…Hmmm! Vol. 12 No. 2 130
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 6: 2008 Revisions to Chapter <797> Vol. 12 No. 2 136
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 5: Verification of Accuracy, Sterility, and Sterilization of Compounded Preparations Vol. 12 No. 1 54
Achievement of USP Chapter <797> Compliance by a 35-Bed Rural Hospital: A Case Study Vol. 11 No. 6 450
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 4: Considerations in Selection and Use of Disinfectants and Antiseptics Vol. 11 No. 6 492
Calculations: High-Technology Compounding and Investigational Dispensing Vol. 11 No. 6 500
Standard Operating Procedure: Vial Crimper--Use, Care, Cleaning, and Maintenance Vol. 11 No. 6 502
Quality-Control Analytical Methods: A Discussion of United States Pharmacopeia Chapter <71> Sterility Tests Vol. 11 No. 5 400
Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels Vol. 11 No. 5 404
Fentanyl 50-mg/mL in 0.9% Sodium Chloride Solution Vol. 11 No. 4 328
Update on the Proposed Revision Process for United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations Vol. 11 No. 4 302
Basics of Compounding: The Responsibilities of Compounding Personnel in Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 2 Vol. 11 No. 4 314
Sufentanil 50-mg/mL in 0.9% Sodium Chloride Solution Vol. 11 No. 4 335
Basics of Compounding for the Implementation of United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 1 Vol. 11 No. 3 230
Quality Control Analytical Methods: The Quality of Sterility Testing Vol. 11 No. 1 52
BioBullet: Innovative Pharmaceutical Compounding for Treating Cattle Vol. 10 No. 6 428
Quality-Control Analytical Methods: Sterility Failure Investigations Vol. 10 No. 5 372
Teaching Lab Renovation: University of Texas at Austin College of Pharmacy Combines Sterile and Nonsterile Compounding Lab Spaces Vol. 10 No. 4 277
Quality Control Analytical Methods: A Guide to Quality Control Testing for the Compounding Pharmacist Vol. 10 No. 4 281
Aseptic Compounding in New Zealand and the Use of Still Air Boxes Vol. 10 No. 4 293
Training and Competency Considerations for Pharmacies Providing Compounded Sterile Preparations Vol. 10 No. 4 253
Putting the Science Back into the "Art and Science" of Compounding Vol. 10 No. 4 263
Prevention of Preterm Delivery with Compounded 17a-Hydroxyprogesterone Caproate Vol. 10 No. 3 165
Case Report: Hydroxyprogesterone Caproate Injection for Prevention of Preterm Labor Vol. 10 No. 3 172
Quality-Control Analytical Methods: Particulate Matter in Injections: What is It and What are the Concerns? Vol. 10 No. 3 202
Standard Operating Procedure: Sterility Test for Ophthalmic Solutions Vol. 10 No. 3 218
Controlled Environment Testing Association Applications Guide for the Use of Barrier Isolators in Compounding Sterile Preparations in Healthcare Facilities, Part 2 Vol. 10 No. 3 208
Is Your Cleanroom Clean? An In-depth Look at Cleaning and Disinfecting Agents, Procedures, and Requirements for the Compounding Pharmacist Vol. 10 No. 2 113
Basics of Compounding: Application of the United States Pharmacopeia Bacterial Endotoxins Test to Compounded Sterile Preparations Vol. 10 No. 1 36
How'd They Do That? Vol. 10 No. 1 46
Stability of Morphine Sulfate in Polypropylene Infusion Bags for Use in Patient-Controlled Analgesia Pumps for Postoperative Pain Management Vol. 10 No. 1 69
Meperidine Hydrochloride 50-mg and Atropine Sulfate 0.4-mg/mL Injection Vol. 9 No. 5 390
Morphine Sulfate 16-mg and Atropine Sulfate 0.4-mg/mL Injection Vol. 9 No. 5 394
Morphine Sulfate 5-mg/mL PCA Injection (Concentration May Vary) Vol. 9 No. 5 395
Proposed Revisions to USP Chapter <797> Pharmaceutical Compounding--Sterile Preparations Vol. 9 No. 2 127
PostScription: Experts Everywhere Vol. 9 No. 2 167
USP Chapter <797>: Practical Solutions for Microbiology, Sterility, and Pyrogen Testing Vol. 9 No. 1 11
Using ACDs in the Practice of Pharmacy Vol. 9 No. 1 15
USP Chapter <797> and Preparing for a JCAHO Survey Vol. 9 No. 1 23
Questions and Answers: USP Chapter <797> and JCAHO Compliance Vol. 9 No. 1 29
A Dialogue Concerning Contamination Control Systems: Where Does the Isolator Fit In? Vol. 9 No. 1 33
Quality-Control Analytical Methods: Microbial Testing Aspects of USP <797> for Compounded Sterile Preparations Vol. 9 No. 1 47
Barrier Isolators, Isolators, and Glove Boxes--What's the Difference? Vol. 9 No. 1 53
Standard Operating Procedure: Calculating the Endotoxin Load in Compounded Sterile Preparations Vol. 8 No. 6 466
Calculations Vol. 8 No. 6 468
Quality-Control Analytical Methods: Allowable Endotoxic Levels in Sterile Preparations Vol. 8 No. 6 479
Quality-Control Analytical Methods: USP Chapter <797> Compounded Sterile Preparations Sterility Requirements and Their Relationship to Beyond-Use Dating Vol. 8 No. 5 393
PreScription - Categories of Pharmaceutial Compounding Vol. 8 No. 4 242
A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards Vol. 8 No. 4 251
Clonidine HCl 1.5-mg/mL Injection Vol. 8 No. 3 216
Fluorouracil 1% Ophthalmic Solution Vol. 8 No. 3 217
Morphine Sulfate 25-mg/mL and Ketamine HCl 25-mg/mL Injection Vol. 8 No. 3 220
Testosterone Propionate 100-mg/mL in Oil Injection Vol. 8 No. 3 222
Physical and Chemical Stability of Trepostinil Sodium Injection Packaged in Plastic Syringe Pump Reservoirs. Vol. 8 No. 3 228
Long-Term Stability of Trimix: A Three-Drug Injection Used to Treat Erectile Dysfunction. Vol. 8 No. 3 231
Stability of Zidovudine and Ranitidine in 0.9% sodium Chloride and 5% Dextrose Injections Stored at Ambient Temperature (23 ± 2°C) and 4°C in 50-mL Polyvinylchloride Bags Up to 24 Hours. Vol. 8 No. 3 236
Overview of Chapter <797> "Pharmaceutical Compounding - Sterile Preparations": The Potential Impact for Compounding Pharmacists Vol. 8 No. 2 89
Netilmicin 0.455% Ophthalmic Solution Vol. 8 No. 2 138
Pyridoxine HCl 100-mg/mL Injection, Preservative Free Vol. 8 No. 2 139
Chemical Stability of Phenylephrine HCl After Reconstitution in 0.9% Sodium Chloride Injection for Infusion Vol. 8 No. 2 153
Effect of Freezing, Long-Term Storage and Microwave Thawing on the Stability of Tramadol in 5% Dextrose Infusion in Polyvinyl Chloride Bags Vol. 8 No. 2 156
PostScription: Cleanroom Standards Vol. 8 No. 2 160
Glycerin 50% Injection Vol. 8 No. 1 54
Hydrochloric Acid 0.1-N Injection Vol. 8 No. 1 55
Phenol 5%-in-Oil Injection Vol. 8 No. 1 57
Vancomycin HCl and Heparin Sodium Injection Vol. 8 No. 1 60
Stability of Zidovudine and Dobutamine HCl Injections in 0.9% Sodium Chloride and 5% Dextrose Injections Stored at Ambient Temperature (23 ± 2°C) and 4°C in 50-mL Polyvinyl Chloride Bags Up to 24 Hours Vol. 8 No. 1 73
Containment of Hazardous Particulates in the Compounding Pharmacy Vol. 7 No. 4 281
Stability of Amikacin Sulfate in AutoDose Infusion System Bags Vol. 7 No. 3 230
Autoclaves for the Sterilization of Compounded Parenteral Products Vol. 7 No. 2 114
Technology Spotlight: Barrier Isolators Vol. 7 No. 1 42
Comparison of Endotoxin Testing Methods for Pharmaceutical Products Vol. 6 No. 6 408
Book Review: Sterile Compounding Vol. 6 No. 6 414
Sterile Compounding of Respiratory Inhalation Solutions Vol. 6 No. 6 415
Benzalkonium Chloride 1:750 Solution for Cold Disinfection Vol. 6 No. 6 448
Furosemide 10-mg/mL Injection Vol. 6 No. 6 453
Phenobarbital Sodium 130-mg/mL Injection Vol. 6 No. 6 457
Cleaning and Disinfection Vol. 6 No. 6 466
Sterilization of Talc for Use in Pleurodesis Vol. 6 No. 2 140
New Perspectives on Vancomycin Use in Home Care, Part 2: Delivery Systems Vol. 6 No. 1 55
Barrier Isolators: A New, High-tech Option for the Preparation of Sterile Admixtures Vol. 5 No. 6 422
Sufentanil 25-mcg/mL, Bupivacaine 1-mg/mL Intrathecal Solution Vol. 5 No. 6 455
New Perspectives on Vancomycin Use in Home Care, Part 1 Vol. 5 No. 6 465
Cross-contamination in Porcelain Mortars Vol. 5 No. 6 476
Quality Assurance for Sterile Products Vol. 5 No. 4 246
Sterile Compounding with Barrier-Isolation Technology Vol. 5 No. 4 254
Bacterial Endotoxins and Pyrogens Vol. 5 No. 4 259
Evolution of the United States Pharmacopeia Chapter <1206>: "Sterile Preparations - Pharmacy Practices" Vol. 5 No. 4 265
Sterile Compounding: Excerpts from the Reviews of Current Published Literature Vol. 5 No. 4 278
Analytical Testing Facilities and Products Vol. 5 No. 4 284
Maintenance of the Cleanroom Vol. 5 No. 4 313
Sterile-Product Preparations: Mix or Buy? Vol. 5 No. 1 59
Short Communication: Compounding for Implantable Pumps Vol. 4 No. 4 280
Dry Heat Sterilization of Parenteral Oil Vehicles Vol. 4 No. 3 223
Compounding Intrathecal Medications Vol. 4 No. 1 24
Standard Operating Procedure: Quality Assessment for Injectable Solutions Vol. 3 No. 5 406
Improving the Management, Operations and Cost Effectiveness of Sterile-Product Compounding Vol. 3 No. 4 253
Sterilization and Depyrogenation Principles and Methods Vol. 3 No. 4 263
Sterile Product Compounding: A Comparison of ASHP and USP Guidelines Vol. 3 No. 4 270
Y-Site Stability of Fosphenytoin and Sodium Phenobarbital Vol. 3 No. 1 64
Testing for Bacterial Endotoxins Vol. 2 No. 5 379
Ophthalmic Compounding: Techniques for Achieving Sterility Vol. 2 No. 3 189
Preservation, Sterilization, and Sterility Testing of Ophthalmic Preparations Vol. 2 No. 3 192
An Automated Process for Batch Preparation of Epidural Solutions Containing Bupivacaine Hydrochloride and Fentanyl Citrate Vol. 2 No. 3 214
General Aseptic Procedures Used at a Laminar Airflow Workbench Vol. 2 No. 3 242